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Abstract Mitochondria in primary living hepatocytes were 
visualized in cells transfected with a chimeric plasmid encoding 
for the green fluorescent protein (GFP) of Aequorea victoria 
engineered to be specifically targeted to mitochondria, as 
described recently (Rizzuto et al. (1995) Curt. Biol. 5, 635- 
642). The identification of the fluorescent organelles as authentic 
mitochondria was confirmed by double labeling with rhodamine 
123. Acetylsalicylate treatment of hepatocytes induced in 
mitochondria typical morphological alterations closely analogous 
to the swelling promoted by acetylsalicylate in isolated 
mitochondria. Cyclosporin A, which in isolated mitochondria 
prevents the changes induced by acetylsalicylate, had no 
protective action but induced per se specific alterations in the 
morphology of mitochondria. Moreover, exposure of hepatocytes 
to cyclosporin A followed by acetylsalicylate caused the same 
mitochondrial changes induced by each of the two compounds 
separately. The structural alterations caused by acetylsalicylate 
were constantly associated with a decrease in mitochondrial urea 
synthesis and cell viability. 
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1. Introduction 
Salicylates are known to induce in isolated liver mitochon- 
dria structural and functional alterations very similar to those 
found in Reye's syndrome [14].  Recently, it has been shown 
that the exposure of isolated rat mitochondr ia to 0.5 mM 
acetylsalicylate (ASA) induced all the alterations described 
for the mitochondria l  permeabil ity transit ion (MPT) process 
[5], i.e. large amplitude swelling, permeabil ity to external su- 
crose, collapse of  t ransmembrane potential and efiflux of en- 
dogenous Mg 2+ and accumulated Ca 2+. These alterations 
were fully prevented by either cyclosporin A (CsA) or Mg 2+ 
[6]. 
Despite their clear damaging action on isolated mitochon- 
dria salicylates were not able to induce all the alterations 
when tested in in vivo animal models [3]. This discrepancy 
raises the question of the sensitivity of intracellular mitochon- 
dria to the effect of salicylates when isolated cells are exposed 
to the drug. 
The aim of the present work was to investigate the effect of 
ASA on mitochondria l  morphology and function in primary 
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cultured hepatocytes. Mitochondr ia  were visualized by: 
(i) transfecting the cells with a chimeric plasmid encoding 
for mitochondrial  targeted GFP  (mtGFP)  [7]; and (ii) staining 
with the cationic dye rhodamine 123 accumulated in the ma- 
trix driven by membrane potential [8]. 
The results obtained with this procedure clearly show that 
in primary hepatocyte cultures exposed to 2-5 mM ASA, 
mitochondr ia undergo major and typical changes in structure 
and functionality, accounting for the lower viability and im- 
paired function of the cells. 
2. Materials and methods 
2.1. Animals 
Male rats of the Wistar strain, weighing 180-220 g, were main- 
rained on standard laboratory food and water ad libitum. Experi- 
ments were started at 11:00 h. The animals were heparinized (500 
U/100 g body wt) then anesthetized by the injection of ketamine in- 
traperitoneally (16 mg/100 g body wt). 
2.2. Hepatocyte culture and transfection 
Liver parenchymal cells were isolated by collagenase perfusion ac- 
cording to Seglen [9], with minor modifications [10]. Yields of 3 
4×108 cells/liver with 90-95% viability by trypan blue exclusion 
were routinely obtained. 
After isolation the parenchymal cells were plated in flat-bottomed 
6-well plates (Falcon) precoated with rat tail collagen, at a density of 
6 x 105 cells/well in 2 ml of Williams' medium E containing 10 IU/ml 
penicillin, 10 gg/ml streptomycin, 0.005 gg/ml gentamycin, 0.02 units/ 
ml insulin, and 10% heat-inactivated (56°C for 20 min) fetal calf 
serum. For microscopic observation, the cells were plated onto 24 
mm diameter round coverslips precoated with rat tail collagen. After 
incubation for 3 h at 37°C in an atmosphere of 5% CO2, 95% air, the 
cultures were rinsed twice with prewarmed, HEPES (10 mM) buffered, 
Williams' medium E. Complete Williams' medium E was renewed, 
and the cells incubated overnight. Following overnight culture, hepa- 
tocytes were washed as above and placed in fresh complete Williams' 
medium E. For the transient expression of GFP the cells were trans- 
fected with mtGFP expression plasmid described by Rizzuto et al. [7] 
by the cationic-liposome (DOTAP) method, basically following the 
manufacturer's in tructions. Briefly, DNA and the reagent were mixed 
in a ratio of 1:7 (w/w) and incubated for 15 min at room temperature. 
Finally, the mixture was added with complete Williams' medium E to 
the 3 h plated cells (4 gg per 35 mm well of plasmid DNA) and 
incubated at 37°C overnight. 
2.3. Detection of rntGFP and rhodarnine 123 fluorescence in vivo 
mtGFP fluorescence was observed in living hepatocytes, 36~2 h 
after transfection with a Nikon RCM 8000 real-time confocal micro- 
scope. The coverslip with the mtGFP-transfected cells was placed in a 
chamber kept at 37°C by a thermostat (Medical System Corporation, 
Greenvale, NY) on the microscope stage. The sample was illuminated 
with an argon-ion laser using the 488 nm band. Williams' medium E 
buffered with 15 mM HEPES (pH 7.4) was used for the incubation. 
Hepatocytes were incubated with 10 gM rhodamine 123 (dissolved 
in dimethyl sulfoxide) for 10 min at 37°C, washed several times with 
warm medium and then analyzed as described above. 
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2.4. Determination of urea synthesis and cell viability 
Hepatocytes plated at a density of 1 × 10 6 cells/well in 2 ml of 
complete Williams' medium E were exposed overnight o increasing 
concentrations of acetylsalicylatc and/or cyclosporin and/or butocaine 
(all dissolved in dimethyl sulfoxide, the final concentration of which 
never exceed 0.5% v/v). In the morning, 10 mM ammonium chloride 
plus 5 mM ornithine, or 5 mM asparagine were added to induce urea 
synthesis (mitochondrial nd cytosolic site, respectively). Samples of 
the incubation medium (0.15 ml) were collected at time 0 and after 6 h. 
0.05 ml were used to assay lactate dehydrogenase (LDH) release and 
the remaining was deproteinized in ice-cold perchloric acid (6% final 
concentration) for urea determination [11]. At the end of the experi- 
ment Triton X-100 (0.5% final) was added to each well and a sample 
collected to determine the total LDH. 
a 
2.5. Statistical analysis 
Analysis of variance was used to evaluate differences among multi- 
ple treatment conditions. The Student-Neumann-Keuls te t was then 
employed to test for statistical significance of any observed iffer- 
ences. Values of P > 0.05 were considered to be not significant. 
2.6. Materials 
Cyclosporin A (powder) was kindly provided by Sandoz (Berna, 
Switzerland). Transfection reagent (DOTAP) was obtained from 
Boehringer Mannheim. Collagenase (type IV), acetylsalicylic acid, 
rhodamine 123 and butocaine were purchased from Sigma. All other 
reagents were of the highest grade commercially obtainable. 
3. Results 
3.1. Morphological modifications induced by ASA 
2 days after transfection with the mtGFP  cDNA,  a propor- 
tion (5 10%) of the cells appeared strongly fluorescent, the 
label being restricted to a diffuse network of fine tubular 
structures throughout he cytosol, but excluding the nucleus 
(Fig. la). 
This pattern of  fluorescence is similar to that described in 
other cell types for mitochondria [7,8], though the density of 
these organelles is, as expected, much higher in hepatocytes 
than in other cells. The identification of the fluorescent orga- 
nelles as mitochondria was confirmed by double labeling with 
rhodamine 123 (data not shown). 
Overnight exposure (15-20 h) to concentrations of  ASA 
above 2 mM induced dramatic alterations in mitochondria 
morphology: transition from the 'spaghetti like' pattern of 
the untreated cell (Fig. la) to large cisternal or vacuolar struc- 
tures (Fig. lb,c). These changes resemble the mitochondrial 
swelling found in isolated mitochondria exposed to salicylates 
[2,3,6]. The possibility that these morphological alterations are 
due to an interaction between the recombinant GFP  and ASA 
seems unlikely because the same changes in mitochondrial 
morphology were observed when untransfected ASA-treated 
cells were stained with rhodamine 123 (Fig. lc). Unlike rho- 
damine, which undergoes rapid photobleaching, GFP  fluores- 
cence is very stable even under continuous illumination and 
allows a prolonged observation of  the sample [7]. In addition, 
GFP  fluorescence is unaffected by membrane potential, thus 
allowing the visualization of mitochondrial morphology also 
under conditions of reduced membrane potential. 
Taking advantage of these properties of  mtGFP,  it was 
possible to follow the modifications of mitochondrial shape 
induced by ASA for up to 1 h in the same hepatocyte. Fig. 2 
shows the changes of mitochondrial morphology in a single 
hepatocyte following 30 rain exposure to 5 mM ASA (com- 
pare Fig. 2a with Fig. 2b). In this cell no further modifications 
occurred when the incubation with the drug was prolonged to 
2h .  
b 
C 
Fig. 1. Morphological alterations of mitochondria induced by over- 
night exposure to acetylsalicylate. Confocal images of (a) untreated 
hepatocytes, or (b,c) after overnight incubation with 3 mM ASA. 
Cells were transiently transfected with mtGFP (a,b), or stained with 
rhodamine 123 (c) as described in section 2. Scale bar = 10 lam. 
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Fig. 2. Mitochondria lterations after short-term incubation with 
acetylsalicylate. Confocal images of the same hepatocyte ransfected 
with mtGFP, (a) before and (b) after 30 min treatment with 5 mM 
acetylsalicylate, as described in section 2. Scale bar= 10 [tm. 
Interestingly, during this short-term ASA treatment (ap- 
prox. 2 h), only a minor proportion of the cell population 
(up to 5%) was affected; an overnight exposure to these 
ASA concentrations was required to induce these morpholog- 
ical alterations in most, if not all, hepatocytes. This indicates a
gradual action of the drug suggesting a non uniform sensitiv- 
ity of the cells to ASA. 
ASA did not alter the cell volume, as inferred by: (i) the 
unchanged cell area in panels a and b of Fig. 2, (ii) the lack of 
modification of cell thickness, as estimated from the number 
of sections obtained by confocal scanning of the z-axis. 
3.2. Cyclosporin A action 
Since mitochondria seem to be a specific target of ASA, we 
assayed the possible protective action of CsA. While in iso- 
lated mitochondria CsA was shown to prevent he triggering 
of MPT by ASA [6], in transfected intact hepatocytes CsA did 
not modify the changes induced by ASA. 
Conversely, when cultured hepatocytes were treated over- 
night with 5 laM CsA alone, drastic alterations in mitochon- 
drial morphology were noted. In particular, CsA induced 
shrinkage of mitochondria, with disruption of the typical mor- 
phology of healthy cells (Fig. 3a). These changes are radically 
different from those induced by ASA (Fig. lb,c). Moreover, 
when the cells were pretreated for 1 h with 5 ~tM CsA and 
successively exposed overnight to 3 mM ASA, mitochondria 
assumed a morphology consisting of a mixture of the modifi- 
cations induced by each of the two compounds eparately, 
either in different hepatocytes, or even in the same hepatocyte, 
as shown in Fig. 3b. 
3.3. Cell viability and urea synthesis 
The described morphological changes caused by ASA were 
constantly associated with a decrease of both cell viability and 
functional efficiency estimated by lactic dehydrogenase release 
and ammonia +ornithine-induced urea synthesis, respectively. 
As shown in Table 1, cell viability was dose-dependently re- 
duced by ASA, in either the absence or presence of CsA, 
which, according to this parameter, failed to attenuate ASA 
toxicity. Likewise, CsA plus butocaine (40 gM), a known in- 
hibitor of phospholipase A which plays a protective role in the 
MPT [12], was without any appreciable ffect on ASA-in- 
duced toxicity (data not shown). An inspection of the results 
reported in Table 1 reveals that CsA alone induced a small, 
but statistically significant, damage of the hepatocytes, in- 
creasing the LDH release from 8.26 to 15.53%. These data 
contrast with those of Pastorino et al. [13] who showed 
that, at the same concentration, the immunosuppressor was 
capable of preventing the death of cultured hepatocytes under 
hypoxic conditions. The damaging effect of ASA on intracel- 
lular mitochondria is also indicated by the data relative to 
urea synthesis from ammonium and ornithine reported in Ta- 
ble 2. These data, corrected for cell viability, show that ASA 
induced a statistically significant inhibition of urea produc- 
tion, in agreement with previous findings with freshly pre- 
pared hepatocytes [14]. CsA did not prevent his inhibition 
but, at variance with its action on hepatocyte viability, did 
not affect 'per se' the process of urea synthesis. 
When cytosolic urea synthesis was sustained by 5 mM ar- 
ginine the rate of urea production was not affected, indicating 
that only the part of urea synthesis occurring in mitochondria 
was impaired by ASA. It is noteworthy that the lowest con- 
centration of ASA (1 mM) induced urea synthesis but not 
LDH release. 
4. Discussion 
Cationic dyes such as rhodamine 123 or JC-1 [15] have been 
Table 1 
Hepatocyte viability after overnight exposure 
cyclosporin A
to acetylsalicylate nd 
Additions Lactate dehydrogenase release (% of total) 
+CsA 5 ~M 
None 8.26 _+ 3.15 15.53 _+ 3.58 a
ASA 1 mM 12.89-+2.66 17.18-+5.05 b 
ASA 3 mM 19.16 --_ 3.60 b 23.71 _+ 4.02 b
ASA 5 mM 29.16- + 1.32 b 31.64+0.60 b 
Experimental conditions were as described in section 2; cyclosporin 
A was added 1 h before acetylsalicylate. Values are means + S.D. of 
3 ~, experiments, each one performed in triplicate. 
• ~P<0.01; bP<0.001 vs. no addition. 
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Fig. 3. Effect of cyclosporin A on mitochondrial shape. Confocal 
images of hepatocytes transfected with mtGFP, (a) after overnight 
treatment with 5 p.M cyclosporin A or (b) with 5 p.M cyclosporin A
plus 3 mM ASA, as described in section 2. Scale bar= 10 p.m. 
widely employed to monitor the morphology of mitochondria 
in living ceils, though their use is not devoid of problems, such 
as toxicity and rapid photobleaching [7,16,17]. In addition, 
given that the staining is dependent on membrane potential, 
these dyes are not ideal to study the morphological changes of 
mitochondria under conditions, e.g. anoxia or treatment with 
mitochondrial poisons, which specifically affect mitochondrial 
membrane potential. In this study we have taken advantage of 
the new methodology described by Rizzuto et al. which con- 
sists in the transfection of cells with the cDNA coding for a 
mitochondrial targeted GFP. The consistency of the data ob- 
tained in cells transfected with mtGFP  and controls stained 
with rhodamine 123 not only allows one to exclude artefacts 
due to the specific technique, but is methodologically particu- 
larly relevant because it confirms that expression of mtGFP  is 
non-toxic even in a rather sensitive cell type such as hepato- 
cytes in primary culture. 
By the use of mtGFP,  it has been possible to demonstrate 
that exposure of cells to ASA concentrations in the range 
found in children with severe salicylate intoxication [18] alters 
the morphology of mitochondria rapidly and drastically 'in 
situ'. These alterations consist in swelling and rounding of 
the organelles, reminiscent of the morphological changes ob- 
served at the electron microscope level in isolated mitochon- 
dria exposed to ASA and Ca ~+ [2]. The dramatic alteration 
caused by ASA (up to 3 mM) on mitochondrial morphology 
contrasts with the relatively minor effects of the drug on cell 
viability. These observations, together with the marked reduc- 
tion in mitochondrial urea synthesis and the lack of effect of 
ASA on cell volume and cytosolic urea production, suggest 
that mitochondrial alterations could be a significant compo- 
nent of ASA toxicity, rather than the consequence of a gen- 
eralized modification of cellular homeostasis. As to the me- 
chanism of mitochondrial ASA toxicity, a major difference 
exists between the results obtained in vitro [6] and those re- 
ported here for intact cells. In the former case, ASA toxicity 
not only required a concomitant loading with high Ca 2+ but, 
more importantly, was effectively inhibited by CsA, suggesting 
the involvement of the permeability transition pore [6]. In 
intact cells, on the contrary, CsA had no protective effect 
on either the morphological alterations or the metabolic im- 
pairment induced by ASA. Furthermore, though changes in 
Ca 2+ homeostasis in ASA-treated cells were not studied di- 
rectly, no plasma membrane blebbing, a classical morpholo- 
gical characteristic of impaired cellular Ca 2+ homeostasis, was 
observed in cells undergoing changes in mitochondrial mor- 
phology. The lack of membrane blebbing and of a protective 
effect by CsA thus suggests that the morphological and meta- 
bolic changes induced by ASA in living cells are not due to an 
effect of the salicylate on the MPT. At present, however, it 
cannot be excluded that, due to the limited permeability of the 
plasma membrane to CsA and the presence of non-mitochon- 
drial CsA binding proteins (cyclophilins) [19], the drug never 
reaches, in the cytosol, the effective concentrations needed to 
affect the MPT. Last but not least, CsA presented, on its own, 
a small but significant oxicity towards cultured hepatocytes 
and caused characteristic alterations in mitochondrial mor- 
phology. To our knowledge, these changes in mitochondrial 
shape have not been described previously and their functional 
significance remains undetermined and will require further 
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Table 2 
Effect of acetylsalicylate and cyclosporin A on the rate of urea 
synthesis of primary cultured hepatocytes 
Additions Urea production (nmol/h per 106 living cells) 
+ CsA 5 ~tM 
None 550.56 -+ 52.03 508.70 + 14.97 
ASA 1 mM 472.70_+ 27.42 ~' 482.91 _+ 23.54 "
ASA 3 mM 379.11 _+ 27.80 ~' 404.58 + 19.84 h
ASA 5 mM 380.05 + 25.10 b 400.80 + 20.12 b 
Experimental conditions were as described in section 2; cyclosporin 
A was added 1 h before acetylsalicylate. Values are means + S.D. of 
34  experiments, each one performed in triplicate. 
~'P<0.05; bP<0.001 vs. no addition. 
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